Trastuzumab & Pertuzumab Followed by T-DM1 in MBC

NCT01835236 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Trastuzumab
DRUG: Pertuzumab
DRUG: Paclitaxel
DRUG: Vinorelbine
DRUG: T-DM1

Sponsor

Swiss Cancer Institute